Antigenic variation in cancer metastasis: immune escape versus immune control

Cancer Metastasis Reviews
V SchirrmacherL Beck

Abstract

Antigenic variation in cancer metastasis was observed in a syngeneic murine tumor system consisting of a low metastatic parental tumor line (derived from a methylcholanthrene-induced DBA/2 T lymphoma, Eb), a high metastatic spontaneous variant thereof (ESb), and a low metastatic 'revertant' from ESb (ESb-M). All three lines expressed tumor-associated transplantation antigens (TATA) which elicited specific T cell-mediated antitumor immune reactions in the host. The strongest host response was elicited upon intradermal inoculation. It could be followed by (a) the infiltration of the locally growing tumor by host cells, such as lymphocytes and macrophages, (b) the establishment of specific systemic antitumor immunity, (c) the generation of immune cells capable of transferring protective antitumor immunity into a normal syngeneic recipient, and (d) the generation of tumor specific cytotoxic T lymphocytes (CTL). Anti-TATA CTL were used as typing reagents to investigate the stability or variability in the TATA expression by cloned tumor cell lines. Antigenic variability in the TATA expression was seen under various conditions: (a) clone-dependent variation in the sensitivity to anti-TATA CTL lysis upon prolonged growth in tissue cult...Continue Reading

References

Mar 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·U KimK Bielat
Jun 1, 1976·Journal of the National Cancer Institute·M Glaser, R Herberman
Sep 15, 1978·International Journal of Cancer. Journal International Du Cancer·M FogelM Feldman
Jan 1, 1979·Advances in Cancer Research·H Kobayashi
Jan 1, 1979·Advances in Cancer Research·F C Austin, C W Boone
Apr 1, 1978·The Australian Journal of Experimental Biology and Medical Science·H S WarrenK J Lafferty
Jan 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·T Boon, O Kellermann
Jan 1, 1977·Cold Spring Harbor Symposia on Quantitative Biology·P Lake, N A Mitchison
Jul 1, 1978·Journal of the National Cancer Institute·S BroderT A Waldmann
Jan 1, 1978·Advances in Cancer Research·H B Hewitt
Jan 1, 1978·Advances in Cancer Research·I J FidlerI R Hart
Jan 1, 1979·Advances in Cancer Research·D Naor
Jan 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·W E Biddison, J C Palmer
Oct 1, 1979·British Journal of Cancer·G C DaveyP Alexander
Jul 1, 1978·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D Bellamy, S M Hinsull
Jun 22, 1978·Nature·K Vickerman
Feb 1, 1979·International Journal of Cancer. Journal International Du Cancer·V SchirrmacherM L Lohmann-Matthes
Jun 15, 1977·International Journal of Cancer. Journal International Du Cancer·D ChassouxT R Munro
Oct 1, 1976·Science·P C Nowell
Sep 4, 1975·Nature·S A Eccles, P Alexander
Jul 15, 1974·International Journal of Cancer. Journal International Du Cancer·D V WahlK E Hellström
Apr 1, 1966·Journal of the National Cancer Institute·G I Deichman, T E Kluchareva
Jul 1, 1967·The Journal of Experimental Medicine·J Lindenmann, P A Klein
Jan 1, 1974·Advances in Immunology·K E Hellström, I Hellström
Sep 1, 1967·Proceedings of the National Academy of Sciences of the United States of America·E A BoyseL J Old
Jan 1, 1970·International Archives of Allergy and Applied Immunology·K E FichteliusS Lidén
Mar 1, 1971·American Journal of Clinical Pathology·L T YamW H Crosby
Aug 1, 1981·The Journal of Experimental Medicine·K Bosslet, V Schirrmacher

❮ Previous
Next ❯

Citations

Jan 1, 1984·Cancer Metastasis Reviews·L Larizza, V Schirrmacher
Jan 1, 1990·Urological Research·R Heicappell, R Ackermann
May 1, 1988·Clinical & Experimental Metastasis·J PohlV Schirrmacher
Jul 1, 1985·Clinical & Experimental Metastasis·D R Welch, S P Tomasovic
Sep 1, 1984·European Journal of Cancer & Clinical Oncology·P Altevogt, V Schirrmacher
Jan 1, 1990·The Journal of Cell Biology·G KadmonM Schachner
Sep 1, 1992·The Journal of Cell Biology·G KadmonP Altevogt
Dec 1, 1995·The Journal of Cell Biology·M RuppertP Altevogt
Jan 1, 1983·The Journal of Experimental Medicine·M FogelV Schirrmacher
Aug 1, 1995·The Journal of Experimental Medicine·P AltevogtE C Butcher
Jul 30, 2005·Expert Opinion on Biological Therapy·Volker Schirrmacher
Jul 15, 1994·International Journal of Cancer. Journal International Du Cancer·A KrügerP von Hoegen
Dec 1, 1987·Cancer Treatment Reviews·D R Welch
Feb 1, 1988·Analytical Biochemistry·G Brunner, V Schirrmacher
Oct 15, 1989·International Journal of Cancer. Journal International Du Cancer·I AlgarraK Kärre
Feb 15, 1989·International Journal of Cancer. Journal International Du Cancer·U ZangemeisterV Schirrmacher
Dec 1, 1987·European Journal of Immunology·H J SchildV Schirrmacher
Nov 15, 1984·International Journal of Cancer. Journal International Du Cancer·L LarizzaM Stöhr
Nov 15, 1982·International Journal of Cancer. Journal International Du Cancer·R DzarlievaN F Fusenig
Apr 15, 1986·International Journal of Cancer. Journal International Du Cancer·R HeicappellB Appelhans
Nov 1, 1995·Japanese Journal of Cancer Research : Gann·Y MatsushitaE Sato
Feb 19, 2004·British Journal of Cancer·K W Hunter
Mar 3, 2020·International Journal of Dermatology·Aikaterini MastorakiEmmanouil Pikoulis
May 15, 1987·International Journal of Cancer. Journal International Du Cancer·H J GabiusK Vehmeyer
Feb 1, 2018·Oncotarget·Weiyang LouWeimin Fan
Apr 20, 2013·Oncology Letters·Sha LiDongwei Gao
Nov 15, 1986·International Journal of Cancer. Journal International Du Cancer·P AltevogtV Schirrmacher
Apr 15, 1984·International Journal of Cancer. Journal International Du Cancer·R SchwartzP F Mühlradt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.